Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1.227
Index Copernicus (ICV 2018) – 157.72
MNiSW – 40
Average rejection rate – 84.38%
ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download PDF

Advances in Clinical and Experimental Medicine

2014, vol. 23, nr 2, March-April, p. 197–203

Publication type: original article

Language: English

The Diagnostic Value of C-Reactive Protein in Bacterial Translocation in Experimental Biliary Obstruction

Ibrahim Barut1,A,C,D,E,F, Selcuk Kaya2,B,C,F

1 Department of General Surgery, Suleyman Demirel University Medical School, Isparta, Turkey

2 Department of Microbiology, Suleyman Demirel University Medical School, Isparta, Turkey

Abstract

Background. Many experimental studies have verified that obstructive jaundice (OJ) causes bacterial translocation (BT).
Objectives. The aim of this study was to assess to whether c-Reactive Protein (cRP) can be used to detect bacterial translocation induced by biliary obstruction.
Material and Methods. Twenty rats were divided into two groups containing 10 rats each: sham-operated controls and the obstructive jaundice (OJ) group. all procedures were performed aseptically. after an upper midline incision, the common bile duct (cBD) was identified, mobilized, ligated and divided. The sham-operated animals had a similar incision, followed by mobilization of the cBD, without ligation or division. Ten days after the first operation, a second laparotomy was performed. Blood samples were collected for culture and serum cRP analysis. In addition, liver, spleen, and mesenteric lymph node (MLN) specimens were taken for microbiological culture to determine the presence of BT. BT was considered positive if there was any bacterial growth in the MLN, liver, spleen, or blood cultures; a lack of bacterial growth indicated a negative BT.
Results. The OJ group had significantly higher rates of bacterial translocation than the sham-operated group (p = 0.002). Mean cRP levels (ng/mL) were 8.7 ± 11.8 and 18.6 ± 17.2 in the sham-operated group and the OJ group respectively. There was no significant difference in mean cRP levels between the two groups (p = 0.257). Mean cRP levels were 4.5 ± 4.3 and 24.9 ± 16.4 in the BT (–) and BT (+) groups respectively (p = 0.003). a marked increase in cRP levels paralleled an increase in BT.
Conclusion. This study has demonstrated a direct relationship between BT and cRP levels in an experimental OJ model.

Key words

c reactive protein, bacterial translocation, obstructive jaundice, cholestasis, animal experimentation.

References (59)

  1. Pitiakoudis M, Mimidis K, Tsaroucha AK, Papadopoulos V, Karayiannakis A, Simopoulos C: Predictive value of risk factors in patients with obstructive jaundice. J Int Med Res 2004, 32, 633–638.
  2. Sikuler E, Buchs AE, Yaari A, Keynan A: Hemodynamic characterization of conscious and ketamine-anesthetized bile duct-ligated rats. am J Physiol 1991, 260, 161–166.
  3. Scott-Conner CE, Grogan JB: The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 1994, 57, 316–336.
  4. Lee SS, Girod C, Braillon A, Hadengue A, Lebrec D: Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. am J Physiol 1986, 251, 176–180.
  5. Zimmermann H, Reichen J, Zimmermann A, Sagesser H, Thenisch B, Hoflin F: Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat. Gastroenterology 1992, 103, 579–589.
  6. O’Connor MJ: Mechanical biliary obstruction. a review of the multisystemic consequences of obstructive jaundice and their impact on perioperative morbidity and mortality. am Surg 1985, 51, 245–251.
  7. Greig JD, Krukowski ZH, Matheson NA: Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 1988, 75, 216–219.
  8. Gonullu NN, Canturk NZ, Utkan NZ, Yidirir C, Dulger M: factors affecting surgical mortality and morbidity in patients with obstructive jaundice. Mater Med Pol 1998, 30, 6-11.
  9. Papakostas C, Bezirtzoglou E, Pitiakoudis M, Polychronidis A, Simopoulos C: Endotoxinemia in the portal and the systemic circulation in obstructive jaundice. clin Exp Med 2003, 3, 124–128.
  10. Sakrak O, Akpinar M, Bedirli A, Akyurek N, Aritas Y: Short and long-term effects of bacterial translocation due to obstructive jaundice on liver damage. Hepatogastroenterology 2003, 50, 1542–1546.
  11. Padillo FJ, Muntane J, Montero JL, Briceno J, Mino G, Solorzano G, Sitges-Serra A, Pera-Madrazo C: Effect of internal biliary drainage on plasma levels of endotoxin, cytokines, and c-reactive protein in patients with obstructive jaundice. World J Surg 2002, 26, 1328–1332.
  12. Sung JY, Shaffer EA, Olson ME, Leung JW, Lam K, Costerton JW: Bacterial invasion of the biliary system by way of the portal-venous system. Hepatology 1991, 14, 313–317.
  13. Karsten TM, van Gulik TM, Spanjaard L, Bosma A, van der Bergh Weerman MA, Dingemans KP, Dankert J, Gouma DJ: Bacterial translocation from the biliary tract to blood and lymph in rats with obstructive jaundice. J Surg Res 1998, 74, 125–130.
  14. Thompson JN, Cohen J, Moore RH, Blenkharn JI, McConnell JS, Matkin J, Blumgart LH: Endotoxemia in obstructive jaundice. Observations on cause and clinical significance. am J Surg 1988, 155, 314–321.
  15. Yoshimoto H, Ikeda S, Tanaka M, Matsumoto S: Relationship of biliary pressure to cholangiovenous reflux during endoscopic retrograde balloon catheter cholangiography. Dig Dis Sci 1989, 34, 16–20.
  16. Rank J, Wilson ID: changes in Iga following varying degrees of biliary obstruction in the rat. Hepatology 1983, 3, 241–247.
  17. Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Gouma DJ: Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. J am coll Surg 1995, 181, 567–581.
  18. Deitch EA, Sittig K, Li M, Berg R, Specian RD: Obstructive jaundice promotes bacterial translocation from the gut. am J Surg 1990, 159, 79–84.
  19. Van Leeuwen PA, Boermeester MA, Houdijk AP, Ferwerda CC, Cuesta MA, Meyer S, Wesdorp RI: clinical significance of translocation. Gut 1994, 35, S28–34.
  20. Deitch EA: Multiple organ failure. Pathophysiology and potential future therapy. ann Surg 216, 117–134, 1992.
  21. Nuytinck JK, Goris RJ: Pathophysiology of the adult respiratory distress syndrome (aRDS) and multiple organ failure (MOf) – a hypothesis. Neth J Surg 1985, 37, 131–136.
  22. Reynolds JV, Murchan P, Leonard N, Clarke P, Keane FB, Tanner WA: Gut barrier failure in experimental obstructive jaundice. J Surg Res 1996, 62, 11–16.
  23. Dawiskiba J: The role of endotoxaemia in the development of renal disorders in experimental obstructive jaundice in rats. HPB Surg 1996, 10, 7–10.
  24. Inan M, Sayek I, Tel BC, Sahin-Erdemli I: Role of endotoxin and nitric oxide in the pathogenesis of renal failure in obstructive jaundice. Br J Surg 1997, 84, 943–947.
  25. Turkcapar AG, Ersoz S, Gur U, Yerdel MA, Karaaslan A, Erden E, Kuterdem E: The effect of octreotid on bacterial translocation from the gut. an experimental study. Int Surg 1995, 80, 264–266.
  26. Marshall JC, Christou NV, Meakins JL: The gastrointestinal tract. The “undrained abscess” of multiple organ failure. ann Surg 1993, 218, 111–119.
  27. Ogata Y, Nishi M, Nakayama H, Kuwahara T, Ohnishi Y, Tashiro S: Role of bile in intestinal barrier function and its inhibitory effect on bacterial translocation in obstructive jaundice in rats. J Surg Res 2003, 115, 18–23.
  28. Slocum MM, Sittig KM, Specian RD, Deitch EA: absence of intestinal bile promotes bacterial translocation. am Surg 1992, 58, 305–310.
  29. Kuzu MA, Kale IT, Col C, Tekeli A, Tanik A, Koksoy C: Obstructive jaundice promotes bacterial translocation in humans. Hepatogastroenterology 1999, 46, 2159–64.
  30. Hori Y, Ohyanagi H: Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice. Surg Today 1997, 27, 140–144.
  31. Sileri P, Morini S, Sica GS, Schena S, Rastellini C, Gaspari AL, Benedetti E, Cicalese L: Bacterial translocation and intestinal morphological findings in jaundiced rats. Dig Dis Sci 2002, 47, 929–934.
  32. Ding JW, Andersson R, Soltesz V, Willen R, Loft S, Poulsen HE, Parsson H, Olsson K, Bengmark S: The effect of biliary decompression on bacterial translocation in jaundiced rats. HPB Surg 1993, 7, 99–110.
  33. Van Bossuyt H, Desmaretz C, Gaeta GB, Wisse E: The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat. J Hepatol 1990, 10, 274–279.
  34. Vaishnavi C, Singh S, Kochhar R, Singh G, Singh K: c-reactive protein in patients with gallbladder and biliary tract diseases. Trop Gastroenterol 2004, 25, 73–75.
  35. Mackenzie I, Woodhouse J: c-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction. Intensive care Med 2006, 32, 1344–1351.
  36. Dong Q, Wright JR: Expression of c-reactive protein by alveolar macrophages. J Immunol 1996, 156, 4815–4820.
  37. Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, Klinger MH, Fricke L, Steinhoff J: The kidney as a second site of human c-reactive protein formation in vivo. Eur J Immunol 2003, 33, 152–161.
  38. van der Meer V, Neven AK, van den Broek PJ, Assendelft WJ: Diagnostic value of c reactive protein in infections of the lower respiratory tract: systematic review. BMJ 2005, 331, 26.
  39. Gabay C, Kushner I: acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340, 448–454.
  40. Ranzani OT, Zampieri FG, Forte DN, Azevedo LC, Park M: c-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One. 2013, 8, e59321.
  41. Sierra R, Rello J, Bailen MA, Benitez E, Gordillo A, Leon C, Pedraza S: c-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive care Med 2004, 30, 2038–2045.
  42. Cevikel MH, Ozgun H, Boylu S, Demirkiran AE, Aydin N, Sari C, Erkus M: c-reactive protein may be a marker of bacterial translocation in experimental intestinal obstruction. aNZ J Surg 2004, 74, 900–904.
  43. Alper E, Baydar B, Vatansever S: Does presence of common bile duct stones in patients with acute biliary pancreatitis affect the severity of illness or laboratory findings? Turk J Gastroenterol 2011, 22, 517–522.
  44. Ozdil B, Kece C, Cosar A, Akkiz H, Sandikci M: Potential benefits of combined N-acetylcysteine and ciprofloxacin therapy in partial biliary obstruction. J clin Pharmacol 2010, 5, 1414–1419.
  45. La Greca G, Sofia M, Lombardo R, Latteri S, Ricotta A, Puleo S, Russello D: adjusting ca19-9 values to predict malignancy in obstructive jaundice: influence of bilirubin and c-reactive protein. World J Gastroenterol 2012, 18, 4150–4155.
  46. Pine JK, Fusai KG, Young R: Serum c-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. Eur J Surg Oncol 2009, 35, 605–610.
  47. Deitch EA: Bacterial translocation of the gut flora. J Trauma 1990, 30, S184–189.
  48. Steffen EK, Berg RD: Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes. Infect Immun 1983, 39, 1252–1259.
  49. Ding JW, Andersson R, Soltesz V, Willen R, Bengmark S: Obstructive jaundice impairs reticuloendothelial function and promotes bacterial translocation in the rat. J Surg Res 1994, 57, 238–245.
  50. Aldemir M, Geyik MF, Kokoglu OF, Buyukbayram H, Hosoglu S, Yagmur Y: Effects of ursodeoxycholic acid, glutamine and polyclonal immunoglobulins on bacterial translocation in common bile duct ligated rats. aNZ J Surg 2003, 73, 722–726.
  51. Westhuyzen J, Healy H: Review: Biology and relevance of c-reactive protein in cardiovascular and renal disease. ann clin Lab Sci 2000, 30, 133–143.
  52. Peyrin-Biroulet L, Gonzalez F, Dubuquoy L: Mesenteric fat as a source of c reactive protein and as a target for bacterial translocation in crohn’s disease. Gut 2012, 61, 78–85.
  53. Cicalese L, Sileri P, Green M, Abu-Elmagd K, Kocoshis S, Reyes J: Bacterial translocation in clinical intestinal transplantation. Transplantation 2001, 71, 1414–1417.
  54. Meddah AT, Leke L, Romond MB, Grenier E, Cordonnier C, Risbourg B, Canarelli JP: The effects of mesenteric ischemia on ileal colonization, intestinal integrity, and bacterial translocation in newborn piglets. Pediatr Surg Int 2001, 17, 515–520.
  55. Bolke E, Jehle PM, Graf M, Baier A, Wiedeck H, Steinbach G, Storck M, Orth K: Inflammatory response during abdominal and thyroid surgery: a prospective clinical trial on mediator release. Shock 2001, 16, 334–339.
  56. Glauser MP, Zanetti G, Baumgartner JD, Cohen J: Septic shock: pathogenesis. Lancet 1991, 338, 732–736.
  57. Ito Y, Machen NW, Urbaschek R, McCuskey RS: Biliary obstruction exacerbates the hepatic microvascular inflammatory response to endotoxin. Shock 2000, 14, 599–604.
  58. Ding JW, Andersson R, Soltesz V, Willen R, Bengmark S: The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats. Eur Surg Res 1993, 25, 11–19.
  59. Qin YS, Li QY, Yang FC, Zheng SS: Risk factors and incidence of acute pyogenic cholangitis. Hepatobiliary Pancreat Dis Int 2012, 11, 650–654.